- £180.79m
- £245.39m
- £245.10m
- 60
- 69
- 92
- 90
Annual income statement for Renold, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 165 | 195 | 247 | 241 | 245 |
| Cost of Revenue | |||||
| Gross Profit | 105 | 130 | 162 | 161 | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 155 | 179 | 224 | 211 | 217 |
| Operating Profit | 10.7 | 16.2 | 22.9 | 30.5 | 28.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6.1 | 12.4 | 17.3 | 22.9 | 20.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.6 | 10.2 | 11.8 | 17.1 | 15.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.6 | 10.2 | 11.8 | 17.1 | 15.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.6 | 10.2 | 11.8 | 17.1 | 15.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.007 | 0.045 | 0.06 | 0.076 | 0.083 |
| Dividends per Share |